214337-39-0 Usage
Uses
Used in Medicinal Chemistry:
Benzothiazole, 2-bromo-5-methoxy(9CI) is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a potential candidate in drug discovery, particularly in the development of new therapeutic agents.
Used in Chemical Research:
Benzothiazole, 2-bromo-5-methoxy(9CI) is used as a research compound in the field of organic chemistry. Its properties and reactivity can be studied to understand its potential applications in the synthesis of other complex molecules and materials.
Used in Material Science:
Benzothiazole, 2-bromo-5-methoxy(9CI) is used as a component in the development of new materials with specific properties. Its incorporation into polymers or other materials could lead to the creation of novel materials with unique characteristics, such as improved stability or enhanced reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 214337-39-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,4,3,3 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 214337-39:
(8*2)+(7*1)+(6*4)+(5*3)+(4*3)+(3*7)+(2*3)+(1*9)=110
110 % 10 = 0
So 214337-39-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H6BrNOS/c1-11-5-2-3-7-6(4-5)10-8(9)12-7/h2-4H,1H3
214337-39-0Relevant academic research and scientific papers
Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors
Ramurthy, Savithri,Aikawa, Mina,Amiri, Payman,Costales, Abran,Hashash, Ahmad,Jansen, Johanna M.,Lin, Song,Ma, Sylvia,Renhowe, Paul A.,Shafer, Cynthia M.,Subramanian, Sharadha,Sung, Leonard,Verhagen, Joelle
supporting information; experimental part, p. 3286 - 3289 (2011/06/24)
Two scaffolds based on 5,6-fused heterocyclic backbones were designed and synthesized as Raf kinase inhibitors. The scaffolds were assessed for in vitro pan-Raf inhibition, activity in cell proliferation and target modulation assays, and pharmacokinetic p
Substituted benzazoles and methods of their use as inhibitors of Raf kinase
-
Page 36, (2008/06/13)
New substituted benz-azole compounds, compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
